<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The main components of eucalyptus EO are 1,8-cineol (eucalyptol), limonene, α-pinene, γ-terpinene, and α-terpineol [
 <xref rid="B93-molecules-24-02130" ref-type="bibr" class="xref">93</xref>]. Further, 1,8-cineol and α-pinene are also present in a similar amount in 
 <italic class="italic">E. maideni, E. astrengens, E. cinerea, E. leucoxylon, E. lehmani, E. sideroxylon</italic>, and 
 <italic class="italic">E. bicostata</italic> [
 <xref rid="B94-molecules-24-02130" ref-type="bibr" class="xref">94</xref>], which according to the Polish Pharmacopoeia [
 <xref rid="B33-molecules-24-02130" ref-type="bibr" class="xref">33</xref>], are not sources of eucalyptus EO, despite the fact that the content of 1,8-cineol varies from 49.07 to 83.59%, and α-pinene varies from 1.27 to 5.02% in those plants. The European and British Pharmacopoeia indicate that eucalyptus EO used for medicinal purposes must contain at least 70% 1,8-cineole [
 <xref rid="B95-molecules-24-02130" ref-type="bibr" class="xref">95</xref>].
</p>
